Overview

Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery

Status:
Completed
Trial end date:
2018-12-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the non-inferiority of the study treatment (combined levofloxacin + dexamethasone eye drops) followed by dexamethasone eye drops alone vs. standard treatment in the prevention and treatment of postoperative ocular inflammation and prevention of infection.
Phase:
Phase 3
Details
Lead Sponsor:
NTC srl
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate
Levofloxacin
Ofloxacin
Tobramycin